Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up
- 1 August 1999
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 13 (8) , 1023-1028
- https://doi.org/10.1046/j.1365-2036.1999.00573.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitisAlimentary Pharmacology & Therapeutics, 1996
- Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.Alimentary Pharmacology & Therapeutics, 1996
- Effective Maintenance Treatment of Reflux Esophagitis with Low-Dose LansoprazoleAnnals of Internal Medicine, 1996
- PantoprazoleDrugs, 1996
- Long-Term Therapy for Reflux EsophagitisNew England Journal of Medicine, 1995
- A Comparison of Five Maintenance Therapies for Reflux EsophagitisNew England Journal of Medicine, 1995
- The role of proton pump inhibitors in the treatment of gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1995
- Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.Gut, 1994
- Reflux EsophagitisScandinavian Journal of Gastroenterology, 1990
- Therapy with Omeprazole in Patients With Peptic Ulcerations Resistant to Extended High-Dose Ranitidine TreatmentDigestion, 1988